Archimedes Tech SPAC Partners III Co. Announces the Separate Trading of its Ordinary Shares and Warrants Commencing March 16, 2026

Archimedes Tech SPAC Partners III Co. (Nasdaq: ARCIU) announced that, effective March 16, 2026, it will allow holders of its units from the initial public offering (IPO) to trade the Company’s ordinary shares and warrants separately. The ordinary shares will trade under the ticker "ARCI," while the warrants will be available under "ARCIW." The company confirmed that only whole warrants will be issued upon the separation of units and no fractional warrants will be available. Units that remain unified will continue to be traded on Nasdaq under the symbol "ARCIU."

In order to separate their units, holders must instruct their brokers to contact Odyssey Transfer and Trust Company, the designated transfer agent for the Company. The original offering of units was conducted through a prospectus, accessible via BTIG, LLC. This announcement follows the effectiveness of the Company’s registration statements filed with the Securities and Exchange Commission (SEC) on January 22, 2026.

Archimedes Tech SPAC Partners III Co. is classified as a blank check company, or a special purpose acquisition company (SPAC), established to pursue mergers, asset acquisitions, and similar business combinations primarily in the technology sector—specifically focusing on artificial intelligence, cloud services, and automotive technology.

The announcement also includes cautionary notes regarding forward-looking statements, emphasizing the inherent risks and uncertainties associated with such projections. Forward-looking statements are subject to various conditions that could lead to actual outcomes differing significantly from those anticipated. Investors and stakeholders interested in more detailed information about the registration statements and risk factors can access these documents via the SEC's website.

As Archimedes Tech SPAC Partners III Co. (Nasdaq: ARCIU) prepares for the separate trading of its ordinary shares and warrants on March 16, 2026, there are several strategic considerations for investors. This transition will allow shareholders to customize their investments, enabling the trading of individual securities under the symbols “ARCI” for ordinary shares and “ARCIW” for warrants. With the prevalence of SPACs in the market, particularly those focusing on the technology sector, understanding the potential implications of this separation is critical.

Investors should consider the nature of the underlying business combination that Archimedes Tech SPAC plans to pursue. The company has indicated plans to target assets in high-growth segments such as artificial intelligence, cloud services, and automotive technology. Given the current technological landscape, these sectors are poised for significant expansion, thus providing a favorable backdrop for capitalizing on investment opportunities.

However, caution is warranted. The SPAC model carries inherent risks, including regulatory scrutiny and the potential for market volatility, especially as investors react to information related to a merger or acquisition target. Archimedes Tech SPAC's reliance on forward-looking statements emphasizes the need for careful due diligence. Market participants should review the risk factors outlined in the Company’s filings with the SEC, as these will illuminate potential pitfalls.

In conclusion, the upcoming separation of shares and warrants can provide strategic flexibility for investors. However, careful analysis of both the market environment and the specific business segments targeted by Archimedes Tech SPAC is essential. Investors should remain vigilant about the risks inherent in SPAC investments while also recognizing the potential for significant returns in a rapidly evolving technological landscape. For those inclined toward speculative investments, this may present an intriguing opportunity, albeit with due consideration of the associated risks.